SAVE Act of 2023

The SAVE Act of 2023 amends the Defense Production Act to prioritize securing domestic supply chains for medical materials essential to national defense, directly affecting federal agencies (like HHS and Defense) and manufacturers of critical drugs, devices, and biological products. It requires the President to develop a strategy within 180 days identifying supply chain weaknesses, diversifying sources, and ensuring U.S. competitiveness, with annual progress reports until 2025. The bill also authorizes new federal funding to boost supply chain security for eligible U.S. entities producing critical medical components or technologies. These provisions aim to reduce reliance on foreign sources for medical materials vital to national security.